本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

X4制药

1.68
-0.0900-5.08%
盘后1.700.0200+1.19%19:54 EDT
成交量:78.77万
成交额:136.50万
市值:972.50万
市盈率:0.78
高:1.80
开:1.73
低:1.65
收:1.77
数据加载中...
2021/03/25

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/19

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/19

重要事件披露

8-K - Current report
2021/03/04

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/08

重要事件披露

8-K - Current report
2020/12/30

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/23

重要事件披露

8-K - Current report
2020/11/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/05

重要事件披露

8-K - Current report
2020/10/22

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/16

重要事件披露

8-K - Current report
2020/10/07

重要事件披露

8-K - Current report
2020/10/01

重要事件披露

8-K - Current report